CARDIOVASCULAR
November 25, 2020
Empagliflozin Also Beneficial in Heart-Failure Patients Without Diabetes
November 18, 2020
Warfarin Use Linked to Greater Risk of Requiring Knee, Hip Replacement
November 13, 2020
Liposorber LA-15 System
November 13, 2020
Assessing Cardiovascular Data for Emerging Diabetes Agents
November 12, 2020
Icosapent Ethyl Diminishes CV Events in Patients With Renal Disease
November 4, 2020
Adherence to Lipid-Lowering Drugs Linked to Lower Cancer Mortality
October 14, 2020
FDA Accepts NDA for Avacopan in ANCA-Associated Vasculitis
October 14, 2020
Empagliflozin Efficacious in Reduced Ejection Fraction HF
October 14, 2020
Evinacumab Lowers LDL-C Levels in Familial Hypercholesterolemia
September 30, 2020
Heart Attack Recurrences Down, But Rates Still Remain Unacceptably High
Related CE
$6.97 Per CE Exam or $59 for 12 Lessons
Copyright © 2000 - 2020 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.